Humeral Shaft Fracture With Placement of an Intramedullary Nail Through an Unrecognized Sarcoma

被引:1
作者
Cullen, Mark M. [1 ]
Okwumabua, Ebubechi [2 ]
Flamant, Etienne M. [1 ]
Ferlauto, Harrison R. [1 ]
Brigman, Brian E. [3 ,4 ]
Eward, William C. [3 ,4 ]
机构
[1] Duke Univ, Sch Med, Durham, NC 27705 USA
[2] Univ Houston, Hlth Sci Ctr, Houston, TX USA
[3] Duke Univ, Med Ctr, Dept Orthopaed Surg, Durham, NC USA
[4] Duke Canc Inst, Durham, NC USA
来源
JOURNAL OF THE AMERICAN ACADEMY OF ORTHOPAEDIC SURGEONS GLOBAL RESEARCH AND REVIEWS | 2021年 / 5卷 / 02期
关键词
MALIGNANT FIBROUS HISTIOCYTOMA; BONE; EPIDEMIOLOGY; MANAGEMENT; FIXATION; MFH;
D O I
10.5435/JAAOSGlobal-D-20-00142
中图分类号
R826.8 [整形外科学]; R782.2 [口腔颌面部整形外科学]; R726.2 [小儿整形外科学]; R62 [整形外科学(修复外科学)];
学科分类号
摘要
Case: A 72-year-old man underwent intramedullary nailing of a humeral diaphysis fracture with passage through an unrecognized pathologic fracture. Four months later, a biopsy of a soft-tissue mass in the arm revealed pleomorphic undifferentiated sarcoma. Only after local recurrence and forequarter amputation was the story of a pathologic fracture through undifferentiated pleomorphic sarcomas of bone clear. The patient developed metastatic disease and died after 2 years postoperatively. Discussion: Orthopaedic surgeons should consider sarcoma when assessing patients with fractures of unknown etiology and an inappropriate mechanism because the placement of an intramedullary device through a sarcoma of bone has consequences.
引用
收藏
页数:6
相关论文
共 31 条
  • [1] Consequences and Prevention of Inadvertent Internal Fixation of Primary Osseous Sarcomas
    Adams, Sheila Conway
    Potter, Benjamin K.
    Mahmood, Zakariah
    Pitcher, J. David
    Temple, H. Thomas
    [J]. CLINICAL ORTHOPAEDICS AND RELATED RESEARCH, 2009, 467 (02) : 519 - 525
  • [2] Undifferentiated pleomorphic sarcoma: indolent, tail-like recurrence of a high-grade tumor
    Alpert, Justin S.
    Boland, Patrick
    Hameed, Meera
    Panicek, David M.
    [J]. SKELETAL RADIOLOGY, 2018, 47 (01) : 141 - 144
  • [3] Bartl R., 2009, Osteoporosis: Diagnosis, prevention, therapy
  • [4] Bauze A J, 2003, J Orthop Surg (Hong Kong), V11, P34
  • [5] Bhattacharyya M., 2015, CHALLENGING CONCEPTS
  • [6] Neoadjuvant chemotherapy with doxorubicin and cisplatin in malignant fibrous histiocytoma of bone: A European osteosarcoma intergroup study
    Bramwell, VHC
    Steward, WP
    Nooij, M
    Whelan, J
    Craft, AW
    Grimer, RJ
    Taminau, AHM
    Cannon, SR
    Malcolm, AJ
    Hogendoorn, PCW
    Uscinska, B
    Kirkpatrick, AL
    Machin, D
    Van Glabbeke, MM
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 1999, 17 (10) : 3260 - 3269
  • [7] FRACTURE BRACING THE HUMERUS
    CAMDEN, P
    NADE, S
    [J]. INJURY-INTERNATIONAL JOURNAL OF THE CARE OF THE INJURED, 1992, 23 (04): : 245 - 248
  • [8] Osteoporosis: fracture epidemiology update 2016
    Cauley, Jane A.
    [J]. CURRENT OPINION IN RHEUMATOLOGY, 2017, 29 (02) : 150 - 156
  • [9] Distinguishing stress fractures from pathologic fractures: a multimodality approach
    Fayad, LM
    Kamel, IR
    Kawamoto, S
    Bluemke, DA
    Frassica, FJ
    Fishman, EK
    [J]. SKELETAL RADIOLOGY, 2005, 34 (05) : 245 - 259
  • [10] Secondary causes of osteoporosis
    Fitzpatrick, LA
    [J]. MAYO CLINIC PROCEEDINGS, 2002, 77 (05) : 453 - 468